Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043167 (
pertussis
)
19,595
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This paper reports a one-month-old female with a one-week history of low grade fever and
rhinorrhea
, and one day of intermittent cough and cyanosis. The signs and symptoms are typical for
pertussis
in an infant less than six months old. The incidence of
pertussis
in the neonate and infant appears to be increasing. The disease still carries significant morbidity and mortality, especially in this age group.
Pertussis
should be included in the differential diagnosis of protracted cough with cyanosis or vomiting, persistent
rhinorrhea
, and marked lymphocytosis in children under six months of age.
...
PMID:Pertussis in an infant. 268 10
Seven-week-old 32-week premature triplets were hospitalized because of
rhinorrhea
, cough with color change and posttussive emesis. One infant had a positive direct fluorescent antibody test for Bordetella
pertussis
, so all were treated with 5 days of azithromycin. Two of the infants were subsequently diagnosed with hypertrophic pyloric stenosis and underwent surgical pyloromyotomies 6 and 7 weeks, respectively, after the initial admission.
...
PMID:Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. 1725 89
Pertussis
, also known as whooping cough, is an acute respiratory tract infection that has increased in incidence in recent years. The initial catarrhal stage presents with nonspecific symptoms of malaise,
rhinorrhea
, sneezing, lacrimation, and mild cough. During the paroxysmal stage, severe outbreaks of coughing often lead to the classic high-pitched whooping sound patients make when gasping for breath. The paroxysmal stage is followed by the convalescent stage and resolution of symptoms. Complications vary by age, with infants more likely to experience severe complications such as apnea, pneumonia, seizures, or death. In adolescents and adults, complications are the result of chronic cough. The diagnosis depends on clinical signs and laboratory testing. Both culture and polymerase chain reaction testing can be used to confirm the diagnosis; serologic testing is not standardized or routinely recommended. Although antibiotics have not shown clear effectiveness in the treatment of
pertussis
, they eradicate nasal bacterial carriage and may reduce transmission rates. Macrolide antibiotics such as azithromycin are first-line treatments to prevent transmission; trimethoprim/sulfamethoxazole is an alternative in cases of allergy or intolerance to macrolides. Immunization against
pertussis
is essential for disease prevention. Current recommendations in the United States consist of administering five doses of the diphtheria and tetanus toxoids and acellular
pertussis
(DTaP) vaccine to children before seven years of age, and administering a tetanus toxoid, reduced diphtheria toxoid, and acellular
pertussis
(Tdap) booster between 11 and 18 years of age. Recent efforts have focused on the vaccination of adolescents and adults, with new recommendations for a single dose of the Tdap booster if it has not been previously administered.
...
PMID:Pertussis: a reemerging infection. 2436 71